DUBLIN--(BUSINESS WIRE)--The "Needle Free Injection System Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The future of the ...

Toronto, Ontario--(Newsfile Corp. - August 21, 2025) - NuGen Medical Devices Inc. (NGMD:CA) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis ® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...

DUBLIN--(BUSINESS WIRE)--The "Technology Landscape, Trends and Opportunities in the Global Needle Free Injection System Market" report has been added to ResearchAndMarkets.com's offering. This study ...

Research and Markets has announced the addition of the "Needle-Free Drug Injection Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive ...

LONDON, Oct. 24, 2019 /PRNewswire/ --Roots Analysis has announced the addition of "Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) ...

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Growth ...

Needle-Free Injection System: IntegriMedical has developed a US patented Needle-Free Injection System (N-FIS) that utilizes high-velocity jet stream using mechanical power to effectively and ...

The MarketWatch News Department was not involved in the creation of this content. -- PharmaJet's intramuscular (IM) Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...